Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Christopher Wardell

Concepts (264)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
39
2025
2934
2.070
 Why?
Mutation
21
2022
1288
1.750
 Why?
High-Throughput Nucleotide Sequencing
5
2021
168
1.030
 Why?
Translocation, Genetic
14
2021
263
0.990
 Why?
Whole Body Imaging
1
2025
26
0.970
 Why?
Oncogenes
2
2018
57
0.740
 Why?
Tomography, X-Ray Computed
1
2025
1160
0.660
 Why?
Biliary Tract Neoplasms
1
2018
9
0.600
 Why?
Gene Expression Profiling
14
2022
1029
0.600
 Why?
Cholangiocarcinoma
1
2018
26
0.590
 Why?
Genomics
8
2022
284
0.550
 Why?
Proto-Oncogene Proteins B-raf
3
2022
78
0.530
 Why?
Gene Expression Regulation, Neoplastic
11
2022
824
0.520
 Why?
Prognosis
15
2021
1963
0.430
 Why?
Brain Neoplasms
3
2023
286
0.410
 Why?
Antineoplastic Combined Chemotherapy Protocols
6
2020
1000
0.390
 Why?
Gene Dosage
5
2020
78
0.390
 Why?
Humans
52
2025
50201
0.390
 Why?
Genetic Predisposition to Disease
5
2018
508
0.380
 Why?
Plasma Cells
4
2021
221
0.380
 Why?
Genome, Human
4
2021
110
0.360
 Why?
Evolution, Molecular
2
2021
97
0.360
 Why?
Liver Neoplasms
3
2022
331
0.350
 Why?
DNA Mutational Analysis
7
2020
176
0.340
 Why?
Thalidomide
5
2019
374
0.330
 Why?
DNA Copy Number Variations
4
2021
109
0.330
 Why?
In Situ Hybridization, Fluorescence
11
2023
256
0.320
 Why?
Software
2
2021
273
0.300
 Why?
Monoclonal Gammopathy of Undetermined Significance
4
2017
112
0.300
 Why?
Aged
16
2025
9505
0.290
 Why?
Neoplasm Recurrence, Local
3
2021
630
0.280
 Why?
Chromosome Aberrations
6
2022
295
0.280
 Why?
Middle Aged
18
2025
12356
0.280
 Why?
Carcinoma, Hepatocellular
2
2022
196
0.280
 Why?
Polymorphism, Single Nucleotide
3
2018
484
0.270
 Why?
Male
26
2025
25572
0.270
 Why?
Female
27
2025
26829
0.270
 Why?
Epigenesis, Genetic
4
2018
371
0.260
 Why?
Clonal Evolution
2
2019
56
0.250
 Why?
Chromosomes, Human, Pair 1
2
2019
92
0.250
 Why?
Immunoglobulin Heavy Chains
3
2014
41
0.250
 Why?
Neoplasm Proteins
3
2017
321
0.240
 Why?
Disease Progression
8
2021
821
0.230
 Why?
Gene Regulatory Networks
2
2022
107
0.230
 Why?
Lymphoma, B-Cell, Marginal Zone
1
2023
24
0.210
 Why?
Polycomb Repressive Complex 2
2
2021
46
0.210
 Why?
Chromosomes, Human, Pair 14
5
2014
75
0.210
 Why?
Central Nervous System Neoplasms
1
2023
64
0.210
 Why?
Exome
4
2017
46
0.200
 Why?
STAT2 Transcription Factor
1
2021
6
0.200
 Why?
STAT1 Transcription Factor
1
2021
25
0.200
 Why?
Germ-Line Mutation
2
2021
61
0.200
 Why?
Hematologic Neoplasms
1
2023
99
0.200
 Why?
Li-Fraumeni Syndrome
1
2021
12
0.190
 Why?
Genome-Wide Association Study
3
2018
163
0.190
 Why?
Bone and Bones
1
2025
477
0.190
 Why?
Japan
2
2018
27
0.190
 Why?
Aged, 80 and over
9
2021
3158
0.180
 Why?
Gene Frequency
2
2017
96
0.180
 Why?
Ecosystem
1
2021
64
0.180
 Why?
Neoplasms
2
2020
1233
0.180
 Why?
Cell Cycle
1
2021
226
0.180
 Why?
Glioblastoma
1
2021
90
0.180
 Why?
Exosome Multienzyme Ribonuclease Complex
1
2020
12
0.170
 Why?
Leukemia, Plasma Cell
1
2020
33
0.170
 Why?
DNA Methylation
3
2016
546
0.170
 Why?
Chromosomal Instability
1
2019
16
0.170
 Why?
Genes, myc
1
2019
40
0.160
 Why?
Chromosomes, Human, Pair 4
3
2014
31
0.160
 Why?
Diploidy
2
2017
26
0.160
 Why?
Cell Survival
2
2018
590
0.160
 Why?
Chromosomes, Human, Pair 11
3
2014
54
0.160
 Why?
INDEL Mutation
1
2018
4
0.150
 Why?
Genes, Tumor Suppressor
2
2021
73
0.150
 Why?
Adult
13
2021
13486
0.150
 Why?
Mutagenesis
1
2018
60
0.150
 Why?
Italy
1
2018
26
0.150
 Why?
Genes, Immunoglobulin Heavy Chain
2
2019
13
0.150
 Why?
Transcriptional Elongation Factors
1
2017
17
0.150
 Why?
Chromosomes, Human, Pair 5
1
2017
17
0.150
 Why?
Histone-Lysine N-Methyltransferase
2
2016
57
0.150
 Why?
Transcriptome
4
2021
316
0.150
 Why?
Enhancer Elements, Genetic
1
2017
58
0.140
 Why?
Reproducibility of Results
1
2021
1195
0.140
 Why?
Chromosomes, Human
1
2017
41
0.140
 Why?
Melanoma
1
2020
281
0.140
 Why?
Hepatocytes
1
2018
179
0.140
 Why?
Immunologic Factors
1
2017
112
0.140
 Why?
B-Lymphocytes
2
2016
175
0.130
 Why?
Neoplasms, Multiple Primary
1
2016
43
0.130
 Why?
Neoplasm Metastasis
1
2016
235
0.130
 Why?
Melphalan
2
2013
173
0.130
 Why?
Oligodendroglioma
1
2015
6
0.130
 Why?
Sequence Analysis, DNA
2
2016
236
0.120
 Why?
Endoribonucleases
1
2015
16
0.120
 Why?
ras Proteins
1
2015
64
0.120
 Why?
Skin Neoplasms
1
2020
487
0.120
 Why?
Survival Rate
4
2020
906
0.120
 Why?
Basic Helix-Loop-Helix Transcription Factors
1
2015
40
0.120
 Why?
Endoplasmic Reticulum Stress
1
2015
42
0.120
 Why?
Survival Analysis
5
2015
670
0.120
 Why?
SMN Complex Proteins
1
2014
4
0.120
 Why?
Signal Transduction
5
2022
1612
0.120
 Why?
RNA Processing, Post-Transcriptional
1
2014
24
0.120
 Why?
Mutation Rate
3
2021
36
0.110
 Why?
Cyclin D
1
2013
18
0.110
 Why?
Chromosome Deletion
2
2011
140
0.110
 Why?
Transcription Factors
2
2015
563
0.110
 Why?
Kaplan-Meier Estimate
4
2018
463
0.110
 Why?
Genes, erbB-1
1
2013
8
0.110
 Why?
RNA, Neoplasm
1
2013
45
0.110
 Why?
Nerve Tissue Proteins
1
2015
191
0.110
 Why?
Cell Line, Tumor
4
2022
1390
0.110
 Why?
Chromosome Breakage
1
2013
16
0.110
 Why?
Precursor Cells, B-Lymphoid
1
2013
8
0.110
 Why?
Repressor Proteins
1
2014
149
0.110
 Why?
Germinal Center
1
2013
28
0.110
 Why?
Retrospective Studies
1
2025
6190
0.100
 Why?
RNA Splicing
3
2021
37
0.100
 Why?
Genetic Heterogeneity
1
2012
18
0.100
 Why?
Cell Transformation, Neoplastic
1
2013
181
0.100
 Why?
DNA-Binding Proteins
1
2015
424
0.100
 Why?
Acetyltransferases
1
2011
19
0.100
 Why?
Cyclin-Dependent Kinase Inhibitor p18
1
2011
26
0.100
 Why?
RNA, Messenger
1
2015
1097
0.100
 Why?
Antineoplastic Agents
3
2018
1176
0.100
 Why?
Chromosomes, Human, Pair 17
1
2011
36
0.100
 Why?
DNA, Neoplasm
3
2018
146
0.090
 Why?
Cell Proliferation
3
2022
987
0.090
 Why?
Multivariate Analysis
3
2021
581
0.090
 Why?
TOR Serine-Threonine Kinases
1
2010
77
0.090
 Why?
Phenotype
3
2022
732
0.090
 Why?
Remission Induction
2
2021
206
0.080
 Why?
Tumor Suppressor Protein p53
1
2011
214
0.080
 Why?
Clone Cells
2
2021
78
0.080
 Why?
MicroRNAs
1
2013
349
0.080
 Why?
DNA
1
2012
543
0.080
 Why?
Alleles
2
2021
253
0.080
 Why?
Transcriptional Activation
2
2021
121
0.080
 Why?
Spliceosomes
2
2021
10
0.080
 Why?
Follow-Up Studies
3
2020
2188
0.070
 Why?
Genomic Instability
2
2018
91
0.070
 Why?
Epigenomics
2
2017
67
0.070
 Why?
Risk Factors
3
2021
3644
0.070
 Why?
Loss of Heterozygosity
2
2018
77
0.060
 Why?
Disease-Free Survival
2
2019
450
0.060
 Why?
Treatment Outcome
4
2019
5203
0.060
 Why?
Chromosomes, Human, Pair 20
2
2014
11
0.060
 Why?
Protein Binding
2
2017
655
0.060
 Why?
Liver
2
2022
1122
0.060
 Why?
Genotype
2
2017
542
0.050
 Why?
Histones
2
2016
296
0.050
 Why?
Dexamethasone
2
2019
434
0.050
 Why?
Proportional Hazards Models
2
2015
408
0.050
 Why?
Janus Kinase 1
1
2021
16
0.050
 Why?
Janus Kinase 2
1
2021
25
0.050
 Why?
Nitriles
1
2021
52
0.050
 Why?
Gene Rearrangement
1
2022
73
0.050
 Why?
Organoids
1
2021
36
0.050
 Why?
Syndecan-1
1
2021
72
0.050
 Why?
Microarray Analysis
2
2012
73
0.050
 Why?
Biomarkers, Pharmacological
2
2011
25
0.050
 Why?
Chromosome Mapping
2
2011
158
0.050
 Why?
Polymerase Chain Reaction
2
2013
456
0.050
 Why?
Cell Line
2
2015
1010
0.050
 Why?
Cell Movement
1
2022
245
0.050
 Why?
Pyrazoles
1
2021
111
0.050
 Why?
Alternative Splicing
1
2021
56
0.050
 Why?
Proto-Oncogene Proteins p21(ras)
1
2021
66
0.050
 Why?
Gene Expression Regulation, Leukemic
1
2020
32
0.040
 Why?
Phosphoproteins
1
2021
111
0.040
 Why?
Pyrimidines
1
2021
192
0.040
 Why?
Gene Expression
2
2013
612
0.040
 Why?
Lymphoma, Follicular
1
2020
27
0.040
 Why?
Prospective Studies
2
2016
2396
0.040
 Why?
Protein Disulfide-Isomerases
1
2019
14
0.040
 Why?
Recurrence
1
2021
660
0.040
 Why?
Young Adult
2
2021
4052
0.040
 Why?
Maintenance Chemotherapy
1
2019
49
0.040
 Why?
Syndrome
1
2019
239
0.040
 Why?
Transcription Elongation, Genetic
1
2017
2
0.040
 Why?
Physical Chromosome Mapping
1
2017
7
0.040
 Why?
Genetic Drift
1
2017
3
0.040
 Why?
Gene Knockdown Techniques
1
2018
106
0.040
 Why?
Caspases
1
2018
104
0.040
 Why?
Genetic Loci
1
2017
44
0.040
 Why?
Unfolded Protein Response
1
2017
32
0.040
 Why?
Xenograft Model Antitumor Assays
1
2018
212
0.040
 Why?
Molecular Targeted Therapy
1
2018
121
0.030
 Why?
Mitosis
1
2017
88
0.030
 Why?
Genetic Association Studies
1
2017
115
0.030
 Why?
Genetic Structures
1
2016
1
0.030
 Why?
Algorithms
1
2020
615
0.030
 Why?
Virus Integration
1
2016
8
0.030
 Why?
Comparative Genomic Hybridization
1
2016
46
0.030
 Why?
Risk
1
2017
315
0.030
 Why?
Regulatory Sequences, Nucleic Acid
1
2016
41
0.030
 Why?
Computational Biology
1
2018
214
0.030
 Why?
Nuclear Proteins
1
2017
242
0.030
 Why?
Immunosuppressive Agents
1
2017
226
0.030
 Why?
Tumor Microenvironment
1
2017
222
0.030
 Why?
Minor Histocompatibility Antigens
1
2015
17
0.030
 Why?
MafB Transcription Factor
1
2015
9
0.030
 Why?
Proto-Oncogene Proteins c-maf
1
2015
19
0.030
 Why?
Cytidine Deaminase
1
2015
12
0.030
 Why?
Antibodies, Monoclonal
1
2019
459
0.030
 Why?
RNA Stability
1
2015
24
0.030
 Why?
Patient Selection
1
2016
254
0.030
 Why?
Proto-Oncogene Proteins c-myc
1
2015
50
0.030
 Why?
Amino Acid Sequence
1
2016
576
0.030
 Why?
Chromosomes, Human, Pair 16
1
2014
19
0.030
 Why?
Multiplex Polymerase Chain Reaction
1
2014
11
0.030
 Why?
Cytogenetic Analysis
1
2014
80
0.030
 Why?
Ribonucleoproteins, Small Nuclear
1
2014
5
0.030
 Why?
Flow Cytometry
1
2017
475
0.030
 Why?
Time Factors
1
2021
2909
0.030
 Why?
Introns
1
2014
49
0.030
 Why?
Single-Cell Analysis
1
2014
63
0.030
 Why?
Methylation
1
2014
118
0.030
 Why?
Protein Isoforms
1
2014
118
0.030
 Why?
Down-Regulation
1
2015
342
0.030
 Why?
Base Sequence
1
2015
653
0.030
 Why?
High-Throughput Screening Assays
1
2013
35
0.030
 Why?
Protein Structure, Tertiary
1
2014
249
0.030
 Why?
HeLa Cells
1
2014
256
0.030
 Why?
Molecular Sequence Data
1
2015
795
0.030
 Why?
Osteonectin
1
2013
10
0.030
 Why?
Chromosomes, Human, Pair 7
1
2013
29
0.030
 Why?
Karyotyping
1
2013
83
0.030
 Why?
Azacitidine
1
2013
34
0.030
 Why?
Mass Spectrometry
1
2014
285
0.030
 Why?
Transforming Growth Factor beta1
1
2013
60
0.030
 Why?
Early Detection of Cancer
1
2014
164
0.030
 Why?
Homologous Recombination
1
2013
40
0.030
 Why?
Disease Models, Animal
1
2018
1419
0.030
 Why?
Tumor Suppressor Proteins
1
2013
127
0.030
 Why?
Validation Studies as Topic
1
2012
10
0.030
 Why?
Apoptosis
1
2018
1093
0.030
 Why?
Gene Library
1
2012
42
0.020
 Why?
Laboratories
1
2012
20
0.020
 Why?
Hemizygote
1
2011
6
0.020
 Why?
Predictive Value of Tests
1
2014
921
0.020
 Why?
Drug Resistance, Neoplasm
1
2013
315
0.020
 Why?
Animals
2
2018
13141
0.020
 Why?
Bone Marrow
1
2013
356
0.020
 Why?
Breast Neoplasms
1
2020
1187
0.020
 Why?
Vincristine
1
2010
85
0.020
 Why?
Prednisolone
1
2010
55
0.020
 Why?
Adolescent
1
2021
6459
0.020
 Why?
Oligonucleotide Array Sequence Analysis
1
2011
409
0.020
 Why?
Cluster Analysis
1
2010
233
0.020
 Why?
Precancerous Conditions
1
2010
83
0.020
 Why?
Cyclophosphamide
1
2010
164
0.020
 Why?
Intracellular Signaling Peptides and Proteins
1
2010
139
0.020
 Why?
Clinical Trials as Topic
1
2012
468
0.020
 Why?
Stem Cell Transplantation
1
2010
179
0.020
 Why?
Child
1
2021
6862
0.020
 Why?
Models, Biological
1
2012
722
0.020
 Why?
Sex Factors
1
2011
700
0.020
 Why?
Doxorubicin
1
2010
234
0.020
 Why?
Up-Regulation
1
2010
446
0.020
 Why?
Risk Assessment
1
2013
1255
0.020
 Why?
Prevalence
1
2011
960
0.020
 Why?
Mice
1
2018
5673
0.020
 Why?
Wardell's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (264) concept(s)
_
Co-Authors Expand Description
See all (27) people
_
Similar People Expand Description
See all (32) people
_
Same Department Expand Description
Search Department